Project cooperationUpdated on 22 January 2026
Regulatory Science Partner
Director Future Medicines Institute at Queen's University Belfast
BELFAST, United Kingdom
About
In my current role as Director of the Future Medicines Institute I have established a Regulatory Science function to enable the development of new drugs and devices utilising novel modalities. We have significant dry lab capabilities and are driven to integrate bioinformatic and AI approaches into drug and device development. Our Regulatory Science function is focused on utilising the extensive wet lab capabilities within the Institute to support the development of NAMs. We believe our capabilities combined with our expertise in Regulatory Science would be an asset to a Consortium.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
AI-Driven Microfluidic 3D In Vitro Platform for Multi-Tissue Crosstalk in Drug Testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
MARCO BERZANO
Research Manager and Advisor - Head of Medical Area at Università Politecnica delle Marche
Ancona, Italy
Project cooperation
Seeking Consortia & Expertise Offer for Tool-02 & Tool-03 (Bioprinting Projects)
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Hazal Evecen
Business Development at Galata Innovation
İstanbul, Türkiye
Project cooperation
Translational Evidence Framework for Human-Relevant NAM Validation
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Emilien Nicolas
R&D Preclinical manager at CER Groupe
Aye, Belgium